Document is current
Any future updates will be listed below
-
Authors
Calip, Gregory S. https://orcid.org/0000-0002-7744-3518
Nabulsi, Nadia A.
Hubbard, Colin
Asfaw, Alemseged A.
Lee, Inyoung
Zhou, Jifang
Cueto, Jenilee
Mitra, Debanjali
Ko, Naomi Y.
Hoskins, Kent F.
Law, Ernest H.
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 19 April 2021
Accepted: 10 February 2022
First Online: 28 February 2022
Declarations
:
: GSC reports current employment with Flatiron Health Inc., which is an independent subsidiary of the Roche group and stock ownership in Roche, NN: None, JZ: None, CH: None, AA reports current employment with Merck & Co., Inc., IL: None, NK: Pfizer consulting and grants, KH: None, DM, JC, EHL are employed by Pfizer Inc. JZ, NAN, AAA, CCH, IL, and GSC are employees of UIC which received financial support from Pfizer in connection with the development of the manuscript. NK is a paid consultant to Pfizer. JC, DM, and EHL are shareholders and are employed by Pfizer Inc.
: Approval to conduct this study was obtained from the University of Illinois at Chicago Institutional Review Board 2019–0170.
: Not Applicable.
